There were two instances of high fevers in response to the vaccine during trials, one in a 3-year old participant and the other in a six-year old. The rest of the participants had experienced mild symptoms, said Geng Zeng, the medical director at Sinovac.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OQLtKJ
via IFTTT
0 comments:
Post a Comment